Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance

Citation

Martin, C, Cullinane, C, Kirby, L et al 2018, 'Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance', International Journal of Cancer, vol. 142, no. 10, pp. 2139-2152.

Year

2018

ANU Authors

Field of Research

  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)

Updated:  05 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers